The 62nd Indian Pharmaceutical Congress (IPC), hosted by Indian Hospital Pharmacists’ Association (IHPA), will be held from December 17 to 19, 2010 in Manipal University.
June 6, 2010 (Chicago, Illinois) — An experimental therapy for advanced melanoma has been shown to improve overall survival in patients, and is "on the road" to becoming the "new standard of care," said one of its investigators here at the American Society of Clinical Oncology (ASCO) 2010 Annual Meeting.
Liquidity crunch and growing uncertainty in the Euro zone have not deterred the Karnataka-based pharma companies from expanding their operations and also patent filing in Europe.
Aiming to understand the potential health benefits of rotavirus vaccination and also to develop a national representative data on rotavirus burden and strains in India, the Indian Council of Medical Research (ICMR) will soon embark on task force projects on burden of rotavirus diarrhoea in India under the Indian Rotavirus Surveillance Network.
Although the department of AIDS Control under the Union health ministry has exhausted its allocation almost completely, it failed to achieve the physical targets set for the last financial year.
Amylin Pharmaceuticals, Inc, Eli Lilly and Company and Alkermes, Inc announced that the US Food and Drug Administration (FDA) has classified the Bydureon (exenatide for extended-release injectable suspension) complete response as a Class 2 resubmission and assigned a new Prescription Drug User Fee Act (PDUFA) action date of October 22, 2010.
The Zilver PTX (Cook Medical, Bloomington, IN) polymer-free paclitaxel-eluting peripheral stent shows near-perfect two-year durability and safety in a nonrandomized study presented at the Society for Cardiovascular Angiography and Interventions (SCAI) 2010 Scientific Sessions in San Diego .
The multinational drug company GlaxoSmithKline (GSK), which had run an advertisement blitzkrieg in several national newspapers in the country on cervical cancer vaccine late last year in gross violation of Drugs and Cosmetics Act, 1940 and Drugs and Magical Remedies Act 1954, has been completely absolved of any irregularities by the drug controller general of India (DCGI) Dr Surinder Singh, it is learnt.